|
|
|
|
||
Re: ABBVThere were nothing for ABBV to talk about ELAGOLIX because there was no data available a year ago. Now, they have very good half year and one year efficacy and safety data to give them a base to talk about ELAGOLIX. Very encouraging there is no safety issue related to one year high dose Elagolix in Endo trial result data... |
return to message board, top of board |
Msg # | Subject | Author | Recs | Date Posted |
39543 | Re: ABBV | bier4me | 0 | 7/24/2015 11:04:35 PM |